S
TLSI icon

SignatureFD’s TriSalus Life Sciences TLSI Stock Holding History

SignatureFD’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$400 Hold
100
– – ﹤0.01% 3337
2025
Q4 		$698 Hold
100
– – ﹤0.01% 3173
2025
Q3 		$465 Hold
100
– – ﹤0.01% 3200
2025
Q2 		$545 Hold
100
– – ﹤0.01% 3091
2025
Q1 		$552 Hold
100
– – ﹤0.01% 3155
2024
Q4 		$501 Hold
100
– – ﹤0.01% 3141
2024
Q3 		$461 Hold
100
– – ﹤0.01% 3110
2024
Q2 		$552 Hold
100
– – ﹤0.01% 2979
2024
Q1 		$975 Buy
+100
New +$923 ﹤0.01% 2955

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

SignatureFD's TLSI Position: Q1 2026 in Review

SignatureFD held its TriSalus Life Sciences (TLSI) position steady in Q1 2026 at 100 shares worth $400. The position accounts for ﹤0.01% of the portfolio, ranked #3337.

SignatureFD first reported a position in TLSI in Q1 2024 and has held it in 9 quarters since. The position peaked at $975 in Q1 2024. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • SignatureFD held 100 shares of TriSalus Life Sciences worth $400 as of Q1 2026.
  • SignatureFD left its TriSalus Life Sciences share count unchanged in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #3337 holding.
  • SignatureFD first reported a position in TriSalus Life Sciences in Q1 2024 and has held it in 9 quarters since.
  • SignatureFD's TriSalus Life Sciences position peaked at $975 in Q1 2024.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.